|
|
||||||||
Ann Thorac Surg 2007;83:e14-e16
© 2007 The Society of Thoracic Surgeons
a Division of Thoracic Surgery, Brigham & Womens Hospital, Boston, Massachusetts
b Division of Endocrinology, Diabetes and Hypertension, Brigham & Womens Hospital, Boston, Massachusetts
c Division of Cardiac Surgery, Brigham & Womens Hospital, Boston, Massachusetts
Accepted for publication February 28, 2007.
* Address correspondence to Dr Bueno, Brigham and Womens Hospital, Division of Thoracic Surgery, 75 Francis St, Boston, MA 02115 (Email: rbueno{at}partners.org).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
A 49-year-old woman with refractory hypertension presented with palpitations, fatigue, and abdominal pain. The patient recalled having vague abdominal pains since the age 16 years. The remainder of the patients past medical and surgical history was significant for alopecia, an uncomplicated caesarean delivery at age 26 years and a left oophorectomy through a midline laparotomy at age 45 years. During induction of anesthesia for the oophorectomy, she had a hypertensive crisis. She was found to have a four-fold elevation in serum normetanephrine levels to 3.79 nmol/L (normal, 0 to 0.89 nmol/L) and a normal metanephrine level of 0.30 nmol/L (normal, 0 to 0.49 nmol/L). Twenty-four hour urine collection revealed a creatinine level of 1,103 mg/day, norepinephrine of 314 µg/day (normal, 0 to 100 µg/day), normetanephrine of 973 µg/day (normal, 50 to 650 µg/day), epinephrine <2 µg/day (normal, 0 to 25 µg/day), and metanephrine 93 µg/day (normal, 30 to 350 µg/day). An abdominal computed tomographic scan was unremarkable. Scintigraphy with iodine-123 meta-iodobenzylguanidine (123-iodinated-MIBG) revealed increased uptake in the superior mediastinum only. A computed chest tomographic scan with coronal reconstruction demonstrated a mass in the middle mediastinum extending from the superior vena cava into the aortopulmonary window and the prevascular space (Figs 1A, 1B). The mass also extended into the right and left paratracheal as well as the subcarinal regions. No distinct tissue planes near the distal aortic arch were discerned and numerous presumed small feeding vessels from the bronchial circulation were identified on axial and coronal views. The patient elected to undergo extirpative surgery to prevent further growth and for blood pressure control. A physical examination was notable for blood pressure of 134/89 and a regular heart rate of 90.
|
The patient underwent a median sternotomy. The pericardium was opened anteriorly and then posteriorly to allow adequate exposure of the tumor. The tumor was first completely dissected off the superior vena cava and the brachiocephalic vein (Fig 1C). Upon exploring the aortic margin of the tumor, it was evident that the tumor was both highly vascular and adherent through the pericardium to the arch of the aorta and to the right and main pulmonary arteries. At this point, the patient was placed on cardiopulmonary bypass and cooled to 20°C. The aorta was cross-clamped; cardioprotection was initiated with intermittent cold hyperkalemic blood cardioplegia given through the antegrade route. The ascending aorta was transected just above the level of the sinotubular junction to gain access to the remaining adherent tumor in the aortopulmonary window. The tumor was carefully mobilized en-bloc off the right and main pulmonary arteries, off the subcarinal space as well as the left side of the trachea and left main stem bronchus, where it was attached to the paratracheal lymph nodes and the recurrent laryngeal nerve, which was sacrificed. The tumor was finally dissected free from the lesser curve of the arch of the aorta (Fig 1D) under circulatory arrest. The tumor was adherent to the arch at that point, and the adventitia of the arch was denuded in two places and was repaired using a half size 26 Hemashield tube graft (Boston Scientific, Natick, MA) to replace the inferior portion of the arch. The patient was rewarmed and weaned off cardiopulmonary bypass without difficulty. However, due to excess bleeding from the resected tumor bed, the cavity was packed and the patients chest was left open in the intensive care unit for resuscitation and an anticipated delayed chest closure. Intraoperatively the patient was hemodynamically stable throughout the procedure despite manipulation of the tumor. The patient initially required a tracheostomy and left vocal cord medialization to wean off the ventilator and was eventually decannulated with no difficulties. Postoperative normetanephrine levels had normalized (0.88 nmol/L) 2 weeks after surgery. Histopathology revealed the tumor to be less than 0.1 cm from the periaortic surface (Fig 1D). The final margins were all negative. Immunohistochemical stains were positive for chromogranins, synaptophysin, and protein S-100. The meta-iodobenzylguanidine-1 proliferative index was focally up to 10%.
| Comment |
|---|
|
|
|---|
Preoperative antihypertensive therapy with alpha followed by beta adrenergic blockade and volume loading is crucial in preventing intraoperative hypertensive crises. Metyrosine has been shown to decrease intraoperative requirements for anti-hypertensive medications, vasopressor agents, fluids, and blood products [5, 6]. Another way to potentially prevent intraoperative hypertension is to perform preoperative embolization of feeding vessels to the tumor. This approach could promote tumor necrosis as well as theoretically prevent blood loss during surgery [7]. In our case, the risk of procedure-induced spinal cord paralysis was believed to be high due to the location of the tumor and its bronchial feeding vessels. Furthermore, it was believed that tumor necrosis may induce an uncontrollable hypertensive crisis through catecholamine release. Therefore this approach was not used. We instead chose the protection afforded by cardiopulmonary bypass. Surprisingly we did not note any hypertensive episodes while manipulating the tumor prior to initiating bypass. Intraoperatively, this tumor was found to be posterior to the ascending aorta and adherent to the aorta at the underbelly of the distal arch. Surgical resection of the tumor required first transection of the ascending aorta for exposure and then reconstruction of a significant portion of the involved aorta to repair the consequences of complete resection.
Bleeding in the tumor bed was not unexpected, as these tumors are highly vascular and hemostasis after cardiopulmonary bypass and circulatory arrest is often a problem even under the best of circumstances [1, 2, 4, 7]. We chose to leave the chest open to prevent tamponade until clotting factors were repleted and hemostasis ensured. The loss of the left recurrent nerve was anticipated given the tumors location.
In conclusion, treatment of functional mediastinal paragangliomas requires careful preoperative assessment and a multidisciplinary team involving endocrinologists, cardiac surgeons, and thoracic surgeons. The preoperative management of catecholamine excess is imperative to prevent hypertensive crises. In the case of mediastinal paragangliomas, the early use of cardiopulmonary bypass and plan to reconstruct critical vascular structures must be anticipated. We conclude that the resection of complex mediastinal paragangliomas is feasible.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M.-W. Lin, Y.-L. Chang, Y.-C. Lee, and P.-M. Huang Non-functional paraganglioma of the posterior mediastinum Interact CardioVasc Thorac Surg, September 1, 2009; 9(3): 540 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K Ghayee, B. Havekes, E. P M Corssmit, G. Eisenhofer, S. R Hammes, Z. Ahmad, A. Tessnow, I. Lazurova, K. T Adams, A. T Fojo, et al. Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior Endocr. Relat. Cancer, March 1, 2009; 16(1): 291 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Brown, G. E. Zayas, M. D. Abel, W. F. Young Jr, and H. V. Schaff Mediastinal Paragangliomas: The Mayo Clinic Experience Ann. Thorac. Surg., September 1, 2008; 86(3): 946 - 951. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |